Cargando…
Activation of the A2B adenosine receptor in B16 melanomas induces CXCL12 expression in FAP-positive tumor stromal cells, enhancing tumor progression
The A2B receptor (A2BR) can mediate adenosine-induced tumor proliferation, immunosuppression and angiogenesis. Targeting the A2BR has proved to be therapeutically effective in some murine tumor models, but the mechanisms of these effects are still incompletely understood. Here, we report that pharma...
Autores principales: | Sorrentino, Claudia, Miele, Lucio, Porta, Amalia, Pinto, Aldo, Morello, Silvana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325441/ https://www.ncbi.nlm.nih.gov/pubmed/27590504 http://dx.doi.org/10.18632/oncotarget.11729 |
Ejemplares similares
-
Myeloid-derived suppressor cells contribute to A2B adenosine receptor-induced VEGF production and angiogenesis in a mouse melanoma model
por: Sorrentino, Claudia, et al.
Publicado: (2015) -
Targeting the adenosine A2b receptor in the tumor microenvironment overcomes local immunosuppression by myeloid-derived suppressor cells
por: Morello, Silvana, et al.
Publicado: (2014) -
[(68)Ga]Ga-DOTA-Siglec-9 Detects Pharmacodynamic Changes of FAP-Targeted IL2 Variant Immunotherapy in B16-FAP Melanoma Mice
por: Viitanen, Riikka, et al.
Publicado: (2022) -
The roles of serum CXCL16 in circulating Tregs and gastrointestinal stromal tumor cells
por: Xing, Ya-Nan, et al.
Publicado: (2016) -
The Roles of Serum CXCL16 in Circulating Tregs and Gastrointestinal Stromal Tumor Cells [Retraction]
Publicado: (2023)